Editas Medicine, Inc.
EDIT
$2.35
-$0.11-4.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.52M | 46.38M | 38.90M | 35.84M | 32.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.52M | 46.38M | 38.90M | 35.84M | 32.31M |
| Cost of Revenue | 89.95M | 111.16M | 139.02M | 177.05M | 199.25M |
| Gross Profit | -49.43M | -64.78M | -100.12M | -141.22M | -166.93M |
| SG&A Expenses | 49.90M | 54.90M | 60.68M | 66.02M | 71.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 139.86M | 166.06M | 199.70M | 243.08M | 271.23M |
| Operating Income | -99.34M | -119.68M | -160.80M | -207.24M | -238.92M |
| Income Before Tax | -160.06M | -199.84M | -236.86M | -251.23M | -237.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -160.06 | -199.84 | -236.86 | -251.23 | -237.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -160.06M | -199.84M | -236.86M | -251.23M | -237.09M |
| EBIT | -99.34M | -119.68M | -160.80M | -207.24M | -238.92M |
| EBITDA | -94.06M | -112.04M | -152.28M | -199.13M | -231.32M |
| EPS Basic | -1.88 | -2.38 | -2.85 | -3.04 | -2.88 |
| Normalized Basic EPS | -0.70 | -0.89 | -1.19 | -1.50 | -1.71 |
| EPS Diluted | -1.88 | -2.38 | -2.85 | -3.04 | -2.88 |
| Normalized Diluted EPS | -0.70 | -0.89 | -1.19 | -1.50 | -1.71 |
| Average Basic Shares Outstanding | 354.81M | 340.17M | 332.57M | 330.46M | 329.35M |
| Average Diluted Shares Outstanding | 354.81M | 340.17M | 332.57M | 330.46M | 329.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |